What does the strongest evidence show?
The most comprehensive analysis to date — a 2026 meta-analysis pooling 14 studies with 847 dementia patients — found that music therapy significantly reduces agitation with a moderate effect size of 0.42 [3]. This means the average patient receiving music therapy showed noticeably less agitation than about 66% of those who did not. The analysis included 10 randomized controlled trials and 4 pre-post trials, and found low statistical heterogeneity, meaning the benefit was consistent across different music types and durations [3].
A smaller but well-designed 2014 crossover trial of 42 nursing home residents with moderate-to-severe dementia found that six weeks of individual music therapy reduced the disruptiveness of agitation by a significant margin (effect size 0.50) and also prevented increases in psychotropic medication [4]. This trial directly compared music therapy to standard care and showed that agitation worsened during standard care but improved during music therapy [4].
Why might music therapy not work in practice?
The largest and most recent trial — a 2022 pragmatic study across 54 nursing homes with 976 residents — found that personalized music did not significantly reduce agitated behaviors or antipsychotic medication use compared to usual care [1]. This trial was designed to test how music therapy works in real-world conditions, not in a tightly controlled research setting. The researchers noted that barriers included difficulty engaging frontline nursing staff and challenges in identifying residents' preferred music [1]. This gap between the meta-analysis results and the pragmatic trial suggests that the effectiveness of music therapy depends heavily on how well it is implemented.
The 2022 trial's negative result is particularly important because it is the largest study here and used a cluster-randomized design, which reduces the risk of bias [1]. In contrast, the positive meta-analysis [3] and the 2014 trial [4] involved more controlled delivery of music therapy, often by trained music therapists. This difference implies that simply playing music may not be enough — the way it is delivered, the consistency, and the personalization matter greatly.
So, should families and caregivers try music therapy?
Yes, but with realistic expectations. The evidence shows that music therapy can help, especially when delivered individually by a trained therapist [4] or when tailored to the person's preferences [3]. However, a large pragmatic trial suggests that in busy nursing homes, the benefits may be smaller or harder to achieve [1]. For families caring for a loved one at home, trying personalized music (e.g., songs from their youth) at times of agitation is low-risk and may help, but it is not a guaranteed solution.
For comparison, a 2023 trial of the medication brexpiprazole for agitation in Alzheimer dementia showed a statistically significant but modest improvement (effect size 0.35) over 12 weeks [2]. This is similar in magnitude to the effect of music therapy found in the meta-analysis (0.42) [3]. This suggests that music therapy can be as effective as some medications, without the side effects. However, the 2022 pragmatic trial [1] found no benefit from music, while the medication trial [2] did find benefit — highlighting that real-world implementation of non-drug approaches remains a challenge.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2014 to 2026, 2 from 2024 or later, 2 in Q1 journals, collectively cited 124 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 40 papers retrieved from a database of over 500 million.
Sources used in this answer
Pragmatic Trial of Personalized Music for Agitation and Antipsychotic Use in Nursing Home Residents With Dementia
In a pragmatic cluster-randomized trial across 54 nursing homes with 976 residents, personalized music did not significantly reduce agitated behaviors (measured by the Cohen-Mansfield Agitation Inventory) or antipsychotic use compared to usual care, with barriers including staff engagement and identifying music preferences.
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia
In a 12-week double-blind randomized trial of 345 patients with Alzheimer dementia, the medication brexpiprazole (2 or 3 mg) significantly reduced agitation compared to placebo, with a modest effect size of 0.35 and good tolerability.
The impact of music therapy on agitation in elderly patients with dementia: A systematic review and meta-analysis
A 2026 meta-analysis of 14 studies (847 patients) found that music therapy significantly reduced agitation in dementia with a moderate effect size of 0.42, with low heterogeneity and consistent results across subgroups.
Individual music therapy for agitation in dementia: an exploratory randomized controlled trial.
In a 2014 crossover trial of 42 nursing home residents with moderate-to-severe dementia, six weeks of individual music therapy significantly reduced agitation disruptiveness (effect size 0.50) and prevented increases in psychotropic medication compared to standard care.
Effect of Massage and Touch on Agitation in Dementia: A Meta‐Analysis
A 2025 meta-analysis of 17 randomized trials (980 patients) found that massage and touch significantly reduced agitation in dementia, with hand, head, and foot massage being most effective, and short-term (≤4 weeks) interventions showing greater benefit.
